Skip to Content

Alcon Inc ALC Stock Quote

| Rating as of


Last close prices updated as of Jun 05, 2023, 5:31 PM CET | CHF
  • Last Close 72.10
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Investment Style Large Growth
  • Day Range 71.82  –  72.68
  • Year Range 55.24  –  74.88
  • Market Cap 35.3604 Bil
  • Volume / Avg 526,116.0 /  1.3 Mil
  • Price / Sales 4.41
  • Price / Book 1.98
  • Forward Div Yield 0.29%
  • Trailing Div Yield 0.29%

Morningstar‘s Stock Analysis ALC

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics ALC

Company Profile ALC

Business Description

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Chemin de Blandonnet 8, Royce Bedward, Vernier
Geneva, 1214, CHE
Industry Medical Instruments & Supplies
Employees 25,178

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of ALC’s competitive advantage.

Alcon Inc


The Cooper Companies Inc


Carl Zeiss Meditec AG

−$0.20 (0.28%) −$0.71 (0.20%) −$1.25 (1.12%)
Market Cap
35.36 Bil17.58 Bil9.87 Bil
Medical Instruments & Supplies Medical Instruments & Supplies Medical Instruments & Supplies

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Alcon Inc Stock

Yes. ALC has a forward dividend yield of 0.29%. See ALC’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

ALC’s market cap is 35.36 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

ALC’s stock style is Large Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

ALC’s price/sales is 4.20.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

ALC’s price/forward earnings is 109.36.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

ALC’s price/book is 1.94.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See ALC’s valuation ratios compared to the Market Index.

ALC’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare ALC’s historical performance against its industry peers and the overall market.